Public Health

Resource Center

FDA Alerts

FDA ALERT

FDA Approves Interchangeable Biosimilar for Psoriatic Arthritis, Other Inflammatory Conditions

11/08/2015

Anthony Calabro, MA

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

11/08/2015

Research Summaries

COVID-19 ROUNDUP

Elevated Risks for Patients Hospitalized With COVID-19 at 3 Years, Worldwide Overuse of Antibiotics, Perinatal Health Among Birth Mothers With SARS-CoV-2 Infection, and More

10/28/2024

Anthony Calabro, MA

In this COVID-19 roundup, researchers report on the risk of health issues and death among patients hospitalized with COVID-19 at 3 year-follow-up, the widespread overuse of antibiotics among patients with...

10/28/2024

Research summary

Sharp Rise in Breast Cancer Diagnoses Among Younger Women After 2016

10/28/2024

Anthony Calabro, MA

In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.

10/28/2024

Respiratory Diseases Roundup

Nirmatrelvir-Ritonavir Lacks Benefit for Patients With Long COVID, CDC Updates Recommendations for “Triple Threat” Vaccines, and More

10/24/2024

Anthony Calabro, MA

In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...

10/24/2024

Research Summary

Research Summary

Breast Cancer Mortality Declines, New Cases Rise Among Younger Women

10/08/2024

Anthony Calabro, MA

Breast cancer deaths have fallen by 44% since 1989, according to a new report by the American Cancer Society.

10/08/2024

Conference Coverage

Fatigue, Headache Are Primary Symptoms of Long COVID Among Patients 21 Years of Age or Younger

10/07/2024

Anthony Calabro, MA

Researchers aimed to describe the most common symptoms of long COVID and the progression of symptoms over time. They presented their findings at IDWeek 2023 in Boston, Massachusetts.

10/07/2024

October 2024

Current Issue

October 2024

Volume 64

Issue 9